Discover trends, market shifts, and competitive outlooks for the biologics testing industry through 2025-2034 with The Business Research Company’s reliable data and in-depth research

What Is the Current and Projected Market Size of the Biologics Testing Market Through 2034?

In recent times, there has been a swift expansion in the biologics testing market size. The market is projected to surge from $5.92 billion in 2024 to $6.85 billion in 2025, reflecting a compound annual growth rate (CAGR) of 15.7%. Factors driving this escalation during the historical phase include growth in biologics development, rigorous regulatory standards, effective quality control in bioprocessing, an increase in biopharmaceutical investments, and an expansion of biomanufacturing capacity.

In the coming years, the biologics testing market is poised for swift expansion, and it is projected to reach a valuation of “$12.91 billion by 2029, growing at a compound annual growth rate (CAGR) of 17.2%. The accelerated growth during the forecast period can be credited to the advent of cutting-edge therapies, a rising need for contract testing services, enlargement of biologics pipelines, the worldwide expansion of biopharmaceutical manufacturing, and an increased demand for expedited testing solutions. Key trends during this period will consist of advanced analytical technologies, cell-based assays, next-generation sequencing (NGS), principles of quality by design (QBD), the incorporation of artificial intelligence (AI), and more rapid methods for product launch.

Download a free sample to assess the report’s scope and structure:

https://www.thebusinessresearchcompany.com/sample.aspx?id=10276&type=smp

What Are the Major Market Drivers Behind the Rising Adoption of Biologics Testing Market?

The swift expansion of both the pharmaceutical and biotechnology sectors is anticipated to fuel the growth of the biologics testing market. The key focus of the pharmaceutical industry is on the development and production of drugs for a variety of diseases and health conditions, whereas the biotechnology industry concentrates on implementing technology in biology and healthcare. Biologics testing involves procedures to confirm and measure impurities, check stability, and inspect the immunity response to the drug. The expansion of the pharmaceutical and biotechnology sectors has subsequently promoted advancements in biologics testing technology, like the creation of novel analytical instruments and methods. This progress has facilitated more precise and efficient testing, which helps in reducing the length and cost of introducing new biologics into the market. For example, in July 2024, Eurostat, a governing body based in Belgium, reported that EU pharmaceutical production had grown from €36 billion ($39.4 billion) in 2021 to €44 billion ($46.7 billion) in 2023, indicating substantial growth in the industry. Hence, the fast-paced growth of the pharmaceutical and biotechnology industries is steering the growth of the biologics testing market.

Which Key Market Segments Comprise the Biologics Testing Market and Drive Its Revenue Growth?

The biologics testing market covered in this report is segmented –

1) By Product: Reagents And Kits, Instruments, Other Products

2) By Test Type: Endotoxin Test, Sterility Test, Mycoplasma Tests, Bioburden Tests, Residual Host-Cell Proteins And DNA Detection Tests, Virus Safety Test, Other Test Types

3) By Application: Vaccine Development And Manufacturing, Monoclonal Antibodies Development And Manufacturing, Cellular And Gene Therapy Products Development And Manufacturing, Blood And Blood Products Development And Manufacturing, Other Applications

Subsegments:

1) By Reagents And Kits: ELISA Kits, PCR Kits, Cell Culture Reagents, Other Assay Kits

2) By Instruments: Spectrophotometers, Chromatography Systems, Microplate Readers, Other Analytical Instruments

3) By Other Products: Software, Consumables, Reference Standards

Request customized data on this market:

https://www.thebusinessresearchcompany.com/customise?id=10276&type=smp

Which Areas Are Leading Regions in the Biologics Testing Market Expansion Across the Globe?

North America was the largest region in the biologics testing market in 2024. Asia-Pacific is expected to be the fastest-growing region in the global biologics testing market duirng the forecast period. The regions covered in the biologics testing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

What Are the Strategic Trends Steering theBiologics Testing Market Direction?

Advancements in product technology is becoming a significant trend in the biologics testing market, as companies introduce innovative products to maintain their market stance. For example, in December 2022, Charles River Laboratories International, Inc., a leading non-clinical contract research firm from the United States, introduced a new device called the Endosafe Nexus 200 to its expansive endotoxin testing collection. The Nexus 200, a fully automatic, data-integrity compliant equipment, is a cutting-edge development for Charles River. The device utilizes Endosafe Limulus Amebocyte Lysate (LAL) cartridge technology and is capable of handling simple or complex serial dilutions for the testing of water, in-process, and final products. Operating on the Endosafe EndoScan-V Version 6.1, the system can export data to a Laboratory Information Management System (LIMS) interface, providing increased traceability, security, and data management through an integrated touchscreen.

View the full report here:

https://www.thebusinessresearchcompany.com/report/biologics-testing-global-market-report

How Is the Biologics Testing Market Conceptually Defined?

Biologics testing typically consists of a range of services aimed at evaluating the safety, efficacy, and quality of biological products.

Purchase the full report and get a swift delivery:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=10276

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model